Similac Lawsuit
Families with affected children have filed Similac lawsuits against Abbott Laboratories, claiming the maker of Similac baby formula did not adequately warn the public its products could increase the risk of necrotizing enterocolitis and Cronobactor sakazakii in infants with low birth weights.
Latest Similac Lawsuit Updates
As of November 2024 a total of 710 litigation cases were pending in the NEC MDL 3026. Plaintiffs in Similac baby formula lawsuits allege that Abbott Laboratories was aware its Similac products could potentially cause necrotizing enterocolitis, particularly in babies born prematurely or at a low weight. Plaintiffs filed additional lawsuits after Cronobactor sakazakii infections, which can cause profound internal damage or death, were linked to the Abbott facility in Sturgis, Michigan.
- October 2024: The tide has shifted a bit among state court cases, with a St. Louis jury siding with Abbott Laboratories and Mead Johnson in the latest baby formula trial. The result is somewhat surprising after plaintiffs had prevailed against both companies in past state trials. Abbott was ordered by a jury to pay $495 million in a similar case in July.
In the MDL, trial dates have been proposed for the bellwether cases, with the first case likely to go to trial on May 5, 2025. The court will still need to approve the schedule. - September 2024: The order has been revealed for the four bellwether cases in the baby formula MDL, and a lawsuit involving Similac will be the first to go to trial. The case focuses on premature infant RaiLee Mar, who died after being fed Similac and developing NEC while in the NICU. Counsel has now been directed to set trial dates for the four cases.
- July 2024: Abbott Laboratories went on trial for allegedly causing NEC in Margo Gill's premature daughter. Gill claims Abbott failed to warn about Similac's risks adequately. A St. Louis jury started hearing evidence following a $60 million Enfamil verdict with similar claims. At the end of the trial, the jury awarded $495 million to Gill, $90 million in damages and $400 million in punitive damages. Abbott has said they disagree and will try to overturn the verdict. This verdict, like the $60 million verdict, will influence baby formula litigation as a whole, lawyers familiar with the cases said.
- January 2023: 97 lawsuits were pending in the NEC MDL 3026.
- April 2022: NEC-related baby formula lawsuits filed across the country were consolidated under MDL number 3026 in Illinois.
- April 2022: The FDA established an Incident Management group to work on supply chain and food safety issues after the voluntary recall.
- February 2022: Following an FDA Coordinated Outbreak Response and Evaluation investigation, Abbott Laboratories voluntarily recalled powdered formulas produced in Sturgis.
- September 2021: The CORE network worked with the Centers for Disease Control and Prevention, as well as state and local partners to investigate reports of death and illness in infants who had consumed Abbott products.
There are currently many Similac lawsuits underway, originating from two major sources. Most cases stem from NEC-related illness and death, but the number of cases based on serious infections arising from products linked to the Sturgis production facility is growing.
Why Are People Filing Similac Lawsuits?
People are filing Similac lawsuits because infants have become ill from baby formula. Both NEC and Cronobacter sakazakii have been linked to Similac products.
Cronobacter sakazakii and other serious infections are linked to contamination at Abbott’s manufacturing facility. NEC, associated with formula made with dairy, has caused serious illness and death in premature infants.
Similac and NEC
Similac lawsuits contend that because Abbott knew of the risk of NEC and failed to adequately protect consumers, serious illness and death of newborns occurred. Thus far, there have been no recalls of Similac products because of the risks of NEC.
- Breach of warranty
- Failure to warn about the risk of NEC
- Negligence
- Product is dangerous and defective
NEC is a gastrointestinal disease that inflames the intestinal lining and can lead to tissue death. According to the National Library of Medicine, there is a significant link between this medical and surgical emergency in newborns and baby formula. Studies indicate cow’s milk-based formulas such as Similac increase NEC risk in premature infants.
Similac lawsuits cite many of those studies in their claims. Plaintiffs contend that Abbott Laboratories either didn’t do enough to protect the public from the potential dangers or deliberately misled the public into thinking their products were safe.
Similac and Cronobacter Sakazakii Infections
There are currently 58 active lawsuits pertaining to products produced at Abbott’s Sturgis facility. Many of the claims involved personal injury and/or wrongful death. Abbott Laboratories is also facing a Department of Justice-led criminal investigation.
- Abbott records indicated the company previously destroyed contaminated formula because of bacterial contamination, but didn’t warn the public.
- Violations of health and safety standards led to avoidable product contamination.
Cronobacter bacteria can infect the bloodstream and central nervous system, resulting in developmental and motor impairments, brain abscesses and death. Between December 2021 and March 2022, the FDA and the CDC investigated reports of infant illness and death related to Abbott baby formula products.
Following the voluntary recall and plant shutdown, the U.S. faced a baby formula shortage, which disproportionately affected lower-income families. Although the shortage was originally because of the ongoing disruptions in the global supply chain, the closure of the Sturgis plant dramatically exacerbated the shortage.
Similac Baby Formulas Named in Lawsuits
Similac products named in Cronobacter lawsuits may include all recalled Similac, Alimentum and EleCareproducts from the Sturgis manufacturing plant. The FDA reports these products can be identified with their multi digit number on the bottom of the container.
- Begin with 22 through 37
- Contains K8, SH or Z2
- Have an expiration date of April 1, 2022 or after.
NEC Similac lawsuits include formulas that contain cow’s milk. Even some of the company’s fortified human milk products contain cow’s milk.
- Similac Alimentum
- Similac Alimentum Expert Care
- Similac Human Milk Fortifier
- Similac Human Milk Fortifier Concentrated Liquid
- Similac Human Milk Fortifier Hydrolyzed Protein Concentrated Liquid
- Similac Human Milk Fortifier Powder
- Similac Liquid Protein Fortifier
- Similac NeoSure
- Similac Special Care
- Similac Special Care 20
- Similac Special Care 24
- Similac Special Care 24 High Protein
- Similac Special Care 30
The best way to determine if a formula you purchased and used is included in Similac lawsuits is to consult an experienced lawyer currently handling baby formula lawsuits. They can review your receipts and other documents to confirm if cases are being accepted for a specific formula.
Who Can File a Similac Lawsuit?
Families or caregivers of premature infants who developed NEC or a Cronobacter sakazakii infection after consuming a Similac product may qualify to file a lawsuit. Infants who received the baby formula in a hospital or consumed it at home are both qualified.
An experienced attorney can assess your eligibility to file a suit. Keep all medical records, purchase receipts and any leftover product as evidence.
Mead Johnson’s baby formula brand Enfamil is also currently subject to NEC-related lawsuits. Parents and caregivers of babies who developed NEC after consuming an Enfamil product may be eligible for Enfamil NEC lawsuits. Similac and Enfamil lawsuits are both included in MDL 3026.
What to Expect When Filing a Similac Lawsuit
The discovery process in a Similac lawsuit may be lengthy. It’s crucial to find an experienced attorney with whom you can comfortably work. Most experienced legal firms will typically offer free consultations.
- Assess eligibility and assemble necessary documentation
- Determine the type of suit for your case
- File your suit
- Negotiate settlements or take your case to trial
The courts will distribute any payments deriving from settlements and verdicts to your legal counsel. Your lawyer will then dispense the funds to you.
16 Cited Research Articles
Consumernotice.org adheres to the highest ethical standards for content production and references only credible sources of information, including government reports, interviews with experts, highly regarded nonprofit organizations, peer-reviewed journals, court records and academic organizations. You can learn more about our dedication to relevance, accuracy and transparency by reading our editorial policy.
- United States Judicial Panel on Multidistrict Litigation. (2024, November 1). MDL Statistics Report - Distribution of Pending MDL Dockets by District. Retrieved from https://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_Actions_Pending-November-1-2024_0.pdf
- United States District Court for the Northern District of Illinois, Eastern Division. (2024, October 4). Stipulation Regarding Proposed Trial Dates. Retrieved from https://ecf.ilnd.uscourts.gov/doc1/067131234295
- Pierson, B. & Knauth, D. (2024, July 26). Abbott must pay $495 million in premature infant formula trial, jury finds. Retrieved from https://www.reuters.com/business/healthcare-pharmaceuticals/abbott-must-pay-95-million-premature-infant-formula-trial-jury-finds-2024-07-26/
- Whyte, L et al. (2023, January 23). Abbott Under Federal Criminal Investigation Over Baby Formula. Retrieved from https://www.wsj.com/articles/abbott-under-criminal-investigation-over-baby-formula-11674255871
- Reuters. (2023, January 23). Abbott faces U.S. criminal probe over baby formula, Wall Street Journal Reports. Retrieved from https://www.reuters.com/business/healthcare-pharmaceuticals/abbott-faces-criminal-probe-over-baby-formula-wsj-2023-01-20/
- U. S. Judicial Panel on Multidistrict Litigation. (2023, January 17). MDL Statistic Report – Distribution of Pending MDL Dockets by District. Retrieved from https://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-January-17-2023.pdf
- Abbott. (2022, October). Recall Notice. Retrieved from https://www.similacrecall.com/us/en/home.html
- Ginglen, J. & Butki, N. (2022, August 8). Necrotizing Enterocolitis. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK513357/
- Ablon, M. (2022, July 29). Similac led to premature baby’s death, Charlotte mom claims in lawsuit. Retrieved from https://www.wcnc.com/article/news/health/charlotte-mom-abbott-baby-formula-similac-death/275-f70a93b9-21a8-433c-b85b-5d9e5ea44b0e
- Riley, L. (2022, June 10). New documents show more claims of baby formula illness and death. Retrieved from https://www.washingtonpost.com/business/2022/06/10/baby-formula-deaths-abbott/
- Centers for Disease Control & Prevention. (2022, May 24). Cronobacter and Powdered Infant Formula Investigation. Retrieved from https://www.cdc.gov/cronobacter/outbreaks/infant-formula.html
- Berger, E. (2022, May 18). Why is there a baby formula shortage in the US, and what can parents do? Retrieved from https://theguardian.com/us-news/2022/may/18/baby-formula-shortage-why-is-there-none-what-to-do-causes-explained
- FDA. (2022, February 17). Abbott Voluntarily Recalls Powder Formulas Manufactured at One Plant. Retrieved from https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/abbott-voluntarily-recalls-powder-formulas-manufactured-one-plant
- FDA. (February 2022). FDA Investigation of Cronobacter Infections: Powdered Infant Formula (February 2022). Retrieved from https://www.fda.gov/food/outbreaks-foodborne-illness/fda-investigation-cronobacter-infections-powdered-infant-formula-february-2022
- U.S. Department of Health and Human Services. (n.d.). Necrotizing Enterocolitis. Retrieved from https://www.nichd.nih.gov/health/topics/nec
- FDA. (n.d.). Cronobacter sakazakii. Retrieved from https://www.fda.gov/food/foodborne-pathogens/cronobacter-sakazakii
Calling this number connects you with a Consumer Notice, LLC representative. We will direct you to one of our trusted legal partners for a free case review.
Consumer Notice, LLC's trusted legal partners support the organization's mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.
844-763-0072